Pennsylvania Sues Insulin Makers and the Big Three Pharmacy Benefit Managers Over Prices Allegedly Inflated by More Than 1,000%: What Diabetics Should Know
Pennsylvania Attorney General Dave Sunday has sued Eli Lilly, Novo Nordisk, Sanofi, CVS Caremark, Express Scripts and OptumRx under the state’s consumer protection law, alleging a scheme that drove insulin list prices up by more than 1,000%. Here’s what the lawsuit claims, what it asks for and what you can do now.
